In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...

Dr. Ayo presents his final in the series of Heart and Stroke month preventative care tips in Part 6 during Heart and Stroke awareness ...

Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) or stroke in long-term care residents, according to a study published ...

HealthDay News — Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardial infarction, according to a study published online Feb. 12 in ...

For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...